Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
TC 13172 is a covalent inhibitor of mixed lineage kinase domain-like protein (MLKL).1 It is selective for MLKL over receptor-interacting serine/threonine kinase 1 (RIPK1) and RIPK3 at 10 µM. TC 13172 inhibits necroptosis induced by TSZ, which is a combination of TNF-α, a Smac mimetic, and Z-VAD-FMK, in HT-29 cells (EC50 = 2 nM). It inhibits TSZ-induced oligomerization of MLKL and translocation of MLKL to the plasma membrane in HT-29 cells when used at a concentration of 100 nM.
WARNING This product is not for human or veterinary use.
1. Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-